Cerebral perfusion and stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 353-361

  Markus, H S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; RADIOISOTOPE; TRACER;

ANTERIOR CEREBRAL ARTERY; ARTERIAL GAS; AUTOREGULATION; BLOOD CLOT LYSIS; BLOOD FLOWMETRY; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; HUMAN; HYPERCAPNIA; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PATHOPHYSIOLOGY; PERFUSION PRESSURE; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CEREBRAL ARTERY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

ACUTE DISEASE; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542512079     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.025825     Document Type: Review

References (77)

1. Nehlig A. Metabolism of the central nervous system. In: Mraovitch S, Sercombe R, eds. Neurophysiological basis of cerebral blood flow control: an introduction. London: John Libby, 1996:177-96.
2. Kety SS. Circulation and metabolism of the human brain in health and disease. Am J Med 1950;8:205-17.
3. Riggs HE, Rupp C. Variation in form of the circle of Willis. Arch Neurol 1963;8:8-14.
4. Vander Ecken HM, Adams RD. The anatomy and functional significance of the meningeal arterial anastamoses of the human brain. J Neuropathol Exp Neurol 1953;12:132-57.
5. 99mTc-d,l-HMPAO in the human brain after intra-arterial bolus injection. A kinetic analysis. J Cereb Blood Flow Metab 1988;8:S13-22.
6. Yonas H, Pindzola RP, Johnson DW. Xenon/computed tomography cerebral blood flow and its use in clinical management. Neurosurg Clin North Am 1996;7:605-16.
7. Lev MH, Sagal AZ, Farkas J, et al. Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with thrombolysis. Prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021-8.
8. 2O positron emission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-40.
9. Eicke BM, Tegeler CH. Ultrasonic quantification of blood flow volume. In: Tegeler CH, Babikian VL, Gomez CR, eds. Neurosonology. St Louis: CV Mosby, 1995:100-9.
10. Deane CR, Markus HS. Colour velocity flow measurement. In vitro validation and application to the human carotid arteries. Ultrasound Med Biol 1997;23:447-52.
11. Eyding J, Wilkening W, Postert T. Brain perfusion and ultrasonic imaging techniques. Eur J Ultrasound 2002;16:91-104.
12. Furchcott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
14. Iadecola C, Pelligrino DA, Moskowitz MA, et al. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood flow Metab 1994;14:175-92.
15. White RP, Deane C, Vallance P, et al. Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperaemic response to hypercapnia. Stroke 1998;29:467-72.
16. White RP, Hindley C, Bloomfield PM, et al. The effect of the nitric oxide synthase inhibitor L-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab 1999;19:673-8.
17. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959;39:183-238.
18. Strandgaard S, Olsen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507-10.
19. 2 responses of cerebral blood flow in patients with acute severe head injury. J Neurosurg 1978;48:689-703.
20. Symon L, Branston NM, Strong AJ. Autoregulation in acute focal ischaemia. An experimental study. Stroke 1976;7:547-54.
21. Voldby B. Pathophysiology of subarachnoid haemorrhage. Experimental and clinical data. Acta Neurochir Suppl (Wien) 1988;45:1-6.
22. Panerai RB. Assessment of cerebral pressure autoregulation in humans - a review of measurement methods. Physiol Meas 1998;19:305-38.
23. Tiecks FP, Lam AM, Aaslid R, et al. Comparison of static and dynamic cerebral autoregulation measurements. Stroke 1995;26:1014-19.
24. White RP, Markus HS. Non-invasive determination of impaired dynamic cerebral autoregulation in carotid artery stenosis. Stroke 1997;28:1340-4.
25. Hlatky R, Furuya Y, Valadka AB, et al. Dynamic autoregulatory response after severe head injury. J Neurosurg 2002;97:1054-61.
26. Dawson SL, Panerai RB, Potter JF. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis 2003;16:69-75.
27. Busija DW, Heistad DD. Factors involved in the physiological regulation of the cerebral circulation. Rev Physiol Biochem Pharmacol 1984;101:161-211.
28. Chillon J-M, Baumbach GL. Autoregulation of cerebral blood flow. In: Welch KMA, Caplan LR, Reis DJ, et al, eds. Primer on cerebrovascular diseases. San Diego: Academic Press, 1997:51-4.
29. White R, Vallance P, Markus HS. The effect of nitric oxide synthase inhibition on dynamic cerebral autoregulation in man. Clin Sci (Colch) 2000;99:555-60.
30. Huang Z, Huang PL, Ma J, et al. Enlarged infarcts in endothelial nitric synthase knockout mice are attenuated by nitro-I-arginine. J Cereb Blood Flow Metab 1996;16:981-7.
31. Kuschinsky W. Regulation of cerebral blood flow: an overview. In: Mraovitch S, Sercombe R, eds. Neurophysiological basis of cerebral blood flow control: an introduction. London: John Libby, 1996:245-62.
32. Markus HS, Vallance P, Brown MM. Differential effect of three cyclooxygenase inhibitors on human cerebral blood flow velocity and carbon dioxide reactivity. Stroke 1994;25:1760-4.
33. Thompson BG, Pluta RM, Girton ME, et al. Nitric oxide mediation of chemoregulation but not autoregulation of cerebral blood flow in primates. J Neurosurg 1996;84:71-8.
34. McPherson RW, Kirsch JR, Ghaly RF, et al. Effect of nitric oxide synthase inhibition on the cerebral vascular response to hypercapnia in primates. Stroke 1995;26:682-7.
35. 2 sensitivity from hyperoxia in the rat. J Cereb Blood Flow Metab 1989;9:187-95.
36. 2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke 1988;19:963-9.
37. Huber P, Handa J. Effect of contrast material, hypercapnia, hyperventilation, hypertonic glucose and papaverine on the diameter of cerebral arteries. Invest Radiol 1967;2:17-32.
38. Kleiser B, Widder B. Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke 1992;23:171-4.
39. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001;124:457-67.
40. Gur AY, Bova I, Bornstein NM. Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke 1996;27:2188-90.
41. Roy CS, Sherrington CS. On the regulation of the blood supply of the brain. J Physiol (Lond) 1890;11:85-108.
42. Gjedde A. Brain energy metabolism and the haemodynamic response. In: Jezzard P, Matthews PM, Smith SM, eds. Functional MRI. Oxford: Oxford University Press, 2001:37-65.
43. Siesjo BK. Pathophysiology and treatment of focal cerebral ischaemia. Part 1. Pathophysiology. J Neurosurg 1992;77:169-84.
44. Branston NM, Symon L, Crockard HA, et al. Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon. Exp Neurol 1974;45:195-208.
45. Heiss WD, Hayakawa T, Waltz AG, Cortical neuronal function during ischaemia. Effects of occlusion of one middle artery on single unit activity in cats. Arch Neurol 1976;33:813-20.
46. Sharborough FW, Messick JM, Sundt TM. Correlation of continuous electroencephalograms with cerebral blood flow measurements during carotid endarterectomy. Stroke 1973;4:674-83.
47. Harris RJ, Symon L, Branston NM, et al. Changes in extracellular calcium activity in cerebral ischaemia. J Cereb Blood Flow Metab 1981;1:203-9.
48. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994;36:557-65.
49. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12:723-5.
50. Jones TH, Moraweta RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773-82.
51. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis 1999;9:193-201.
52. Baron JC, Bousser MG, Comar D, et al. Noninvasive tomographic study of cerebral blood flow and oxygen metabolism in vivo: Potentials, limitations and clinical applications to cerebral ischemic disorders. Eur Neurol 1981;20:273-84.
53. Wise RJS, Bernadi S, Frackowiak RSJ, et al. Serial observations on the pathophysiology of acute stroke: the transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain 1983;106:197-222.
54. Marchal G, Beaudouin V, Rioux P, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke: a correlative PET-CT study with voxel-based data analysis. Stroke 1996;27:599-606.
55. rt-PA Stroke Study Group. Tissue plasminogen activator for ischemic stroke. N Engl J Med 1995;333:1581-7.
56. Young AR, Touzani O, Derlon JM, et al. Early reperfusion in the anaesthetized baboon reduces brain damage following middle cerebral artery occlusion. Stroke 1997;28:632-8.
57. Heiss WD, Graf R, Wienhard K, et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1994;14:892-902.
58. Fisher M. The ischemic penumbra and the therapeutic time window. In: Fisher M, Bogousslavsky J, eds. Current review of cerebrovascular disease, 4th ed. Philadelphia: Current Medicine, 2002:35-43.
59. Baird A, Benfield A, Schlaug G, et al. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic imaging. Ann Neurol 1997;41:581-9.
60. Barber P, Darby D, Desmond PM, et al. Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted magnetic resonance imaging. Neurology, 1998;51:418-26.
61. Schellinger PD, Jansen O, Fiebach JB, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-28.
62. Kidwell CS, Saver JL, Mattiello J, et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000;47:462-9.
63. Kidwell CS, Saver JL, Starkman S, et al. Late secondary ischemic injury in patients receiving intra-arterial thrombolysis. Ann Neurol 2002;52:698-703.
64. Wintermark M, Maeder P, Thiran J-P, et al. Simultaneous measurements of regional cerebral blood flows by perfusion-CT and stable xenon-CT: a validation study. Am J Neuroradiol 2001;22:905-14.
65. Wintermark M, Reichhart M, Cuisenaire O, et al. Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients. Stroke 2002;33:2025-31.
66. Na DG, Ryoo JW, Lee KH, et al. Multiphasic perfusion computed tomography in hyperacute ischemic stroke: comparison with diffusion and perfusion magnetic resonance imaging. J Comput Assist Tomogr 2003;27:194-206.
67. Warach S. Stroke neuroimaging. Stroke 2003;34:345-7.
68. Wong KS, Gao S, Chan YL, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002;52:74-81.
69. del Zoppo GJ, Hallenback JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 2000;98:V73-81.
70. Kogure T, Kogure K. Molecular and biochemical events within the brain subjected to cerebral ischemia. Clin Neurosci 1997;4:179-83.
71. Choi DW, Lobner D, Dugan LL. Glutumate receptor-mediated neuronal death in the ischemic brain. In: Hsu C, ed. Ischemic stroke: from basic mechanisms to new drug development. Basel: Karger, 1998:2-13.
72. ++ release. Trends Pharmacol Sci 1995;16:356-9.
73. Samdani AF, Dawson TM, Dawson VI. Nitric oxide synthase in models of focal ischaemia. Stroke 1997;28:1283-8.
74. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet 1997;349:79-83.
75. Hossman KA. Peri-infarct depalarizations. Cerebrovosc Brain Metab Rev 1996;8:195-208.
76. Takano K, Latour LL, Formato JE, et al. The role of spreading depression in focal ischemia evaluated by diffusion mapping. Ann Neurol 1996;39:308-18.
77. Vila N, Castillo, Davalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000;31:2325-9.